Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-016044
Filing Date
2024-04-26
Accepted
2024-04-26 06:10:40
Documents
1
Period of Report
2024-04-26

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 449278
  Complete submission text file 0001493152-24-016044.txt   450622
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15911 | Film No.: 24878428
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)